vardenafil-dihydrochloride and Heart-Defects--Congenital

vardenafil-dihydrochloride has been researched along with Heart-Defects--Congenital* in 1 studies

Trials

1 trial(s) available for vardenafil-dihydrochloride and Heart-Defects--Congenital

ArticleYear
The efficacy of bosentan combined with vardenafil in the treatment of postoperative pulmonary hypertension in children with congenital heart disease: A protocol of randomized controlled trial.
    Medicine, 2021, 01-08, Volume: 100, Issue:1

    Topics: Bosentan; Child; Drug Therapy, Combination; Endothelin Receptor Antagonists; Heart Defects, Congenital; Humans; Hypertension, Pulmonary; Phosphodiesterase 5 Inhibitors; Postoperative Complications; Randomized Controlled Trials as Topic; Vardenafil Dihydrochloride

2021